"Immunity, Heterologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The immunological phenomenon by which exposure to some organisms or vaccines can profoundly alter the host's response to subsequent exposure to unrelated (heterologous) organisms or vaccines.
Descriptor ID |
D064789
|
MeSH Number(s) |
G12.450.418
|
Concept/Terms |
Immunity, Heterologous- Immunity, Heterologous
- Off Target Effects of Vaccines
- Non-Target Heterologous Effects of Vaccines
- Non Target Heterologous Effects of Vaccines
- Non-Specific Effects of Vaccines
- Non Specific Effects of Vaccines
- Vaccines Non-Specific Effect
- Vaccines Non-Specific Effects
- Heterologous Immunity
- Non-Targeted Immunity
- Immunity, Non-Targeted
- Non Targeted Immunity
- Non-Specific Effects of Vaccine
- Non Specific Effects of Vaccine
- Vaccine Non-Specific Effect
- Vaccine Non-Specific Effects
- Non-Target Heterologous Effects of Vaccine
- Non Target Heterologous Effects of Vaccine
- Off Target Effects of Vaccine
- Heterologous Effects of Vaccines
- Vaccines Heterologous Effect
- Vaccines Heterologous Effects
- Heterologous Effects of Vaccine
- Vaccine Heterologous Effect
- Vaccine Heterologous Effects
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Heterologous".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Heterologous".
This graph shows the total number of publications written about "Immunity, Heterologous" by people in this website by year, and whether "Immunity, Heterologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunity, Heterologous" by people in Profiles.
-
Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals. Front Immunol. 2021; 12:820126.
-
Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires. mBio. 2017 Dec 05; 8(6).
-
Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. J Infect Dis. 2016 10 01; 214(7):1020-9.
-
Vaccination and heterologous immunity: educating the immune system. Trans R Soc Trop Med Hyg. 2015 Jan; 109(1):62-9.